NCT01877902Unknown不适用
STUDY OF USE OF PEMETREXED IN PATIENTS WITH NON-SMALL LUNG CANCER METASTATIC IN ANDALUSIAN PUBLIC HEALTH SYSTEM
Fundación Pública Andaluza Progreso y Salud18 个研究点 分布在 1 个国家目标入组 190 人开始时间: 2011年10月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 190
- 试验地点
- 18
- 主要终点
- Determine utilization profile (line treatment and scheme used) of pemetrexed in patients with non-small cell lung cancer metastatic (CPNMm) in Andalusia.
研究概览
简要总结
STUDY OF USE OF PEMETREXED IN PATIENTS WITH NON-SMALL LUNG CANCER METASTATIC IN ANDALUSIAN PUBLIC HEALTH SYSTEM
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients over 18 years
- •Confirmed diagnosis of metastatic NSCLC
- •Pemetrexed Starts 1st line (either induction or maintenance) in any of the following periods:
- •January 1, 2010 to March 31, 2010
- •October 1, 2011 to December 31, 2011
排除标准
- •Patients receiving pemetrexed within a clinical trial protocol because it is an experimental environment that does not reflect clinical practice.
结局指标
主要结局
Determine utilization profile (line treatment and scheme used) of pemetrexed in patients with non-small cell lung cancer metastatic (CPNMm) in Andalusia.
时间窗: 12 months
次要结局
- 1) Determine the progression-free survival and overall survival 2) Evaluate the degree of adherence in prescribing pemetrexed patients with CPNMm in Andalusia approved indications, the recommendations of the Pharmacy and Therapeutics Committees and(12 months)
研究者
研究点 (18)
Loading locations...
相似试验
终止
1 期
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNCT00923273National Cancer Institute (NCI)42
已完成
2 期
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or AbdomenLung NeoplasmsMesotheliomaNon-small Cell Lung CancerNCT00316225Eli Lilly and Company31
已完成
4 期
Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation StrategiesNon-small Cell Lung CancerNCT03607149Centre Georges Francois Leclerc11
已完成
2 期
Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Non Small Cell Lung CancerNCT00370292Eli Lilly and Company19
已完成
2 期
To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)Non-small Cell Lung CancerNCT00191191Eli Lilly and Company226